• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

II类HMG-CoA还原酶中控制底物结合和辅因子特异性的结构特征及结构域运动

Structural Features and Domain Movements Controlling Substrate Binding and Cofactor Specificity in Class II HMG-CoA Reductase.

作者信息

Miller Bradley R, Kung Yan

机构信息

Department of Chemistry, Bryn Mawr College , 101 North Merion Avenue, Bryn Mawr, Pennsylvania 19010, United States.

出版信息

Biochemistry. 2018 Feb 6;57(5):654-662. doi: 10.1021/acs.biochem.7b00999. Epub 2017 Dec 21.

DOI:10.1021/acs.biochem.7b00999
PMID:29224355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6170158/
Abstract

The key mevalonate pathway enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (HMGR) uses the cofactor NAD(P)H to reduce HMG-CoA to mevalonate in the production of countless metabolites and natural products. Although inhibition of HMGR by statin drugs is well-understood, several mechanistic details of HMGR catalysis remain unresolved, and the structural basis for the wide range of cofactor specificity for either NADH or NADPH among HMGRs from different organisms is also unknown. Here, we present crystal structures of HMGR from Streptococcus pneumoniae (SpHMGR) alongside kinetic data of the enzyme's cofactor preferences. Our structure of SpHMGR bound with its kinetically preferred NADPH cofactor suggests how NADPH-specific binding and recognition are achieved. In addition, our structure of HMG-CoA-bound SpHMGR reveals large, previously unknown conformational domain movements that may control HMGR substrate binding and enable cofactor exchange without intermediate release during the catalytic cycle. Taken together, this work provides critical new insights into both the HMGR reaction mechanism and the structural basis of cofactor specificity.

摘要

关键的甲羟戊酸途径酶3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶(HMGR)利用辅因子NAD(P)H将HMG-CoA还原为甲羟戊酸,用于生产无数的代谢产物和天然产物。尽管他汀类药物对HMGR的抑制作用已被充分了解,但HMGR催化的一些机制细节仍未解决,不同生物体的HMGR对NADH或NADPH具有广泛辅因子特异性的结构基础也尚不清楚。在此,我们展示了肺炎链球菌HMGR(SpHMGR)的晶体结构以及该酶辅因子偏好的动力学数据。我们的SpHMGR与其动力学偏好的NADPH辅因子结合的结构表明了NADPH特异性结合和识别是如何实现的。此外,我们的结合HMG-CoA的SpHMGR结构揭示了以前未知的大的构象结构域运动,这些运动可能控制HMGR底物结合,并在催化循环中实现辅因子交换而无需中间产物释放。综上所述,这项工作为HMGR反应机制和辅因子特异性的结构基础提供了重要的新见解。

相似文献

1
Structural Features and Domain Movements Controlling Substrate Binding and Cofactor Specificity in Class II HMG-CoA Reductase.II类HMG-CoA还原酶中控制底物结合和辅因子特异性的结构特征及结构域运动
Biochemistry. 2018 Feb 6;57(5):654-662. doi: 10.1021/acs.biochem.7b00999. Epub 2017 Dec 21.
2
New Crystallographic Snapshots of Large Domain Movements in Bacterial 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase.细菌3-羟基-3-甲基戊二酰辅酶A还原酶中大结构域运动的新晶体学快照
Biochemistry. 2018 Oct 2;57(39):5715-5725. doi: 10.1021/acs.biochem.8b00869. Epub 2018 Sep 19.
3
Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.人HMG-CoA还原酶催化部分的晶体结构:对活性调节和催化作用的见解。
EMBO J. 2000 Mar 1;19(5):819-30. doi: 10.1093/emboj/19.5.819.
4
The structure of the catalytic portion of human HMG-CoA reductase.人类HMG-CoA还原酶催化部分的结构。
Biochim Biophys Acta. 2000 Dec 15;1529(1-3):9-18. doi: 10.1016/s1388-1981(00)00134-7.
5
Crystal structure of archaeal HMG-CoA reductase: insights into structural changes of the C-terminal helix of the class-I enzyme.古菌 HMG-CoA 还原酶的晶体结构:对 I 类酶 C 末端螺旋结构变化的深入了解。
FEBS Lett. 2019 Mar;593(5):543-553. doi: 10.1002/1873-3468.13331. Epub 2019 Feb 22.
6
Computational study of conformational changes in human 3-hydroxy-3-methylglutaryl coenzyme reductase induced by substrate binding.基于配体结合诱导的人源 3-羟基-3-甲基戊二酰辅酶 A 还原酶构象变化的计算研究。
J Biomol Struct Dyn. 2019 Oct;37(16):4374-4383. doi: 10.1080/07391102.2018.1549508. Epub 2019 Jan 28.
7
Binding of NADP triggers an open-to-closed transition in a mycobacterial FabG β-ketoacyl-ACP reductase.烟酰胺腺嘌呤二核苷酸磷酸(NADP)的结合引发了分枝杆菌FabGβ-酮酰基-ACP还原酶从开放状态到关闭状态的转变。
Biochem J. 2017 Mar 7;474(6):907-921. doi: 10.1042/BCJ20161052.
8
Kinetic characterization of an oxidative, cooperative HMG-CoA reductase from Burkholderia cenocepacia.洋葱伯克霍尔德菌氧化型协同HMG-CoA还原酶的动力学特性
Biochim Biophys Acta. 2014 Feb;1844(2):457-64. doi: 10.1016/j.bbapap.2013.11.015. Epub 2013 Dec 3.
9
Structural mechanism for statin inhibition of HMG-CoA reductase.他汀类药物抑制HMG-CoA还原酶的结构机制。
Science. 2001 May 11;292(5519):1160-4. doi: 10.1126/science.1059344.
10
Characterization of an HMG-CoA reductase from Listeria monocytogenes that exhibits dual coenzyme specificity.来自单核细胞增生李斯特菌的具有双重辅酶特异性的HMG-CoA还原酶的特性分析。
Biochemistry. 2006 Dec 5;45(48):14397-406. doi: 10.1021/bi0614636.

引用本文的文献

1
Integrated Multi-Omics Investigation of Gypenosides' Mechanisms in Lowering Hepatic Cholesterol.绞股蓝总皂苷降低肝脏胆固醇机制的多组学综合研究
Biomolecules. 2025 Aug 21;15(8):1205. doi: 10.3390/biom15081205.
2
Improving Cofactor Promiscuity of HMG-CoA Reductase from Through Rational Design.通过合理设计提高来自[具体来源未给出]的HMG-CoA还原酶的辅因子混杂性。
Biomolecules. 2025 Jul 7;15(7):976. doi: 10.3390/biom15070976.
3
Identifying Opportunity Targets in Gram-Negative Pathogens for Infectious Disease Mitigation.确定革兰氏阴性病原体中用于减轻传染病的机会靶点。
ACS Cent Sci. 2025 Jan 3;11(1):25-35. doi: 10.1021/acscentsci.4c01437. eCollection 2025 Jan 22.
4
pH-dependent reaction triggering in PmHMGR crystals for time-resolved crystallography.pH 依赖反应触发的 PmHMGR 晶体用于时间分辨晶体学。
Biophys J. 2024 Mar 5;123(5):622-637. doi: 10.1016/j.bpj.2024.02.003. Epub 2024 Feb 6.
5
Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor.用非他汀类抑制剂靶向粪肠球菌 HMG-CoA 还原酶。
Commun Biol. 2023 Apr 3;6(1):360. doi: 10.1038/s42003-023-04639-y.
6
Antibacterial Effect of Some Eukaryotic Sterol Biosynthesis Inhibitors.某些真核生物甾醇生物合成抑制剂的抗菌作用
Adv Biomed Res. 2022 Oct 29;11:90. doi: 10.4103/abr.abr_291_21. eCollection 2022.
7
A fungal tolerance trait and selective inhibitors proffer HMG-CoA reductase as a herbicide mode-of-action.真菌耐受性特性和选择性抑制剂为 HMG-CoA 还原酶提供了除草剂作用模式。
Nat Commun. 2022 Sep 22;13(1):5563. doi: 10.1038/s41467-022-33185-0.
8
An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia.从原子水平看 HMG-CoA 还原酶:治疗高胆固醇血症的靶标酶。
Molecules. 2020 Aug 26;25(17):3891. doi: 10.3390/molecules25173891.
9
[Blood lipid metabolic profile of overweight/obese boys aged 9-12 years].9至12岁超重/肥胖男孩的血脂代谢谱
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Aug;22(8):874-881. doi: 10.7499/j.issn.1008-8830.2005077.
10
Debottlenecking mevalonate pathway for antimalarial drug precursor amorphadiene biosynthesis in .消除甲羟戊酸途径瓶颈以实现青蒿二烯生物合成,青蒿二烯是抗疟药物前体,存在于……中
Metab Eng Commun. 2020 Jan 2;10:e00121. doi: 10.1016/j.mec.2019.e00121. eCollection 2020 Jun.

本文引用的文献

1
Polder maps: improving OMIT maps by excluding bulk solvent.Polder 图:通过排除主体溶剂来改进 OMIT 图。
Acta Crystallogr D Struct Biol. 2017 Feb 1;73(Pt 2):148-157. doi: 10.1107/S2059798316018210.
2
Isoprenoid drugs, biofuels, and chemicals--artemisinin, farnesene, and beyond.类异戊二烯药物、生物燃料及化学品——青蒿素、法尼烯及其他。
Adv Biochem Eng Biotechnol. 2015;148:355-89. doi: 10.1007/10_2014_288.
3
Kinetic characterization of an oxidative, cooperative HMG-CoA reductase from Burkholderia cenocepacia.洋葱伯克霍尔德菌氧化型协同HMG-CoA还原酶的动力学特性
Biochim Biophys Acta. 2014 Feb;1844(2):457-64. doi: 10.1016/j.bbapap.2013.11.015. Epub 2013 Dec 3.
4
The increasingly complex mechanism of HMG-CoA reductase.HMG-CoA 还原酶的作用机制日益复杂。
Acc Chem Res. 2013 Nov 19;46(11):2416-26. doi: 10.1021/ar3003267. Epub 2013 Jul 30.
5
A novel role for coenzyme A during hydride transfer in 3-hydroxy-3-methylglutaryl-coenzyme A reductase.辅酶 A 在 3-羟-3-甲基戊二酰辅酶 A 还原酶中氢化物转移过程中的新作用。
Biochemistry. 2013 Aug 6;52(31):5195-205. doi: 10.1021/bi400335g. Epub 2013 Jul 24.
6
From fields to fuels: recent advances in the microbial production of biofuels.从田间到燃料:生物燃料微生物生产的最新进展
ACS Synth Biol. 2012 Nov 16;1(11):498-513. doi: 10.1021/sb300074k. Epub 2012 Nov 5.
7
Effect of levels of acetate on the mevalonate pathway of Borrelia burgdorferi.乙酰辅酶 A 水平对伯氏疏螺旋体甲羟戊酸途径的影响。
PLoS One. 2012;7(5):e38171. doi: 10.1371/journal.pone.0038171. Epub 2012 May 31.
8
Towards automated crystallographic structure refinement with phenix.refine.利用phenix.refine实现自动化晶体学结构精修
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67. doi: 10.1107/S0907444912001308. Epub 2012 Mar 16.
9
Optimization of a heterologous mevalonate pathway through the use of variant HMG-CoA reductases.通过使用变体 HMG-CoA 还原酶优化异源甲羟戊酸途径。
Metab Eng. 2011 Sep;13(5):588-97. doi: 10.1016/j.ymben.2011.07.001. Epub 2011 Jul 28.
10
Specific inhibitions of annonaceous acetogenins on class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae.对肺炎链球菌 II 类 3-羟-3-甲基戊二酰辅酶 A 还原酶的具有特异性抑制作用的番荔枝乙酰基酶。
Bioorg Med Chem. 2011 Jun 1;19(11):3512-9. doi: 10.1016/j.bmc.2011.04.019. Epub 2011 Apr 20.